|Bid||12.10 x 800|
|Ask||12.16 x 3200|
|Day's Range||12.11 - 12.55|
|52 Week Range||6.50 - 25.10|
|Beta (3Y Monthly)||2.82|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Opened Cronos Device Labs, New Global R&D Center in Israel Appointed Dr. Todd Abraham as Chief Innovation Officer Announced Agreement to Acquire.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today announced that it has entered into a definitive agreement to acquire four of Redwood Holding Group, LLC’s operating subsidiaries (collectively, “Redwood”). Redwood manufactures, markets and distributes hemp-derived cannabidiol (CBD) infused skincare and other consumer products online and through retail and hospitality partner channels in the United States under the brand, Lord Jones™. Redwood was co-founded in 2017 by Robert Rosenheck and Cindy Capobianco.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today announced that it has entered into an agreement to acquire an 84,000 square foot GMP compliant fermentation and manufacturing facility in Winnipeg, Canada from Apotex Fermentation Inc. (“AFI”). As previously announced, Cronos Group has entered into a partnership with Ginkgo Bioworks, Inc. (“Ginkgo”) to produce cultured cannabinoids.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today announced that Dr. Todd Abraham has been appointed as the Company’s Chief Innovation Officer. In this role, Dr. Abraham will be responsible for advancing Cronos Group’s research and development initiatives in cannabinoids with a focus on identifying new disruptive technologies and adopting best practices and innovations from adjacent consumer goods industries.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”), will announce its financial results for the second quarter ended June 30, 2019, and hold its Second Quarter 2019 Earnings Conference Call on Thursday, August 8, 2019 at 8:30 a.m. EDT. A live audio webcast of the earnings call will be available on the Company’s website at https://ir.thecronosgroup.com/events-presentations. The call will be archived on the Company’s website for replay.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) reports that at its Annual Meeting of Shareholders on June 19, 2019 there were 610 shareholders voting in person or by proxy holding in total 261,290,314 common shares, representing 78.2% of the total number of common shares outstanding.
Cronos Group Inc. (“Cronos Group” or the “Company”) (CRON.TO) (CRON.TO), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at three industry conferences in June. Mr. Gorenstein will present at the Piper Jaffray 39th Annual Consumer Marketplace Conference on Thursday June 6, 2019 at 1:30 p.m. ET in New York, NY, the Jefferies 2019 Healthcare Conference on Friday June 7, 2019 at 11:30 a.m. ET in New York, NY and the Stifel 2019 Cross Sector Insight Conference on Wednesday June 12, 2019 at 1:15 p.m. ET in Boston, MA. The presentations will be available on the Investors section of the Company’s website at ir.thecronosgroup.com/events-presentations.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, will hold its 2019 Annual Meeting of Shareholders on Wednesday, June 19, 2019 at 10 a.m. ET at the offices of Blake, Cassels & Graydon LLP located at 199 Bay Street, Suite 4000, Commerce Court West, Toronto. The Notice of Meeting and Management Information Circular are available on the Governance section of the Company’s website at https://ir.thecronosgroup.com/investor-relations. A live audio webcast and replay of the meeting will also be available in the Investor Relations section of the Company’s website.
MediPharm Labs Corp. (LABS.V) (MEDIF) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce that it has entered into a multi-year supply agreement with Cronos Group Inc. (CRON) (CRON) (“Cronos Group”). MediPharm Labs will supply Cronos Group with approximately $30 million of high-quality private label cannabis concentrate over 18-months, and, subject to certain renewal and purchase options, potentially up to $60 million over 24-months. In addition, Cronos Group has selected MediPharm Labs’ state of the art extraction facility in Barrie, Ontario, as a preferred partner to fulfill certain of its processing needs, under a separate tolling arrangement.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”), is pleased to announce that it has entered into a multi-year supply agreement with MediPharm Labs Corp. (LABS.V) (MEDIF) (“MediPharm Labs”). MediPharm Labs will supply Cronos Group with approximately $30 million of high-quality private label cannabis concentrate over 18-months, and, subject to certain renewal and purchase options, potentially up to $60 million over 24-months.
Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs, a State-of-the-Art Vaporizer R&D Initiative NatuEra.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today announced that it is expanding its global infrastructure network and innovation capabilities with the opening of a cannabinoid device R&D facility, based in Israel (“Cronos Device Labs”). The state-of-the-art facility supports Cronos Group’s efforts to develop next-generation vaporizer products that are designed specifically for cannabinoid applications. Cronos Device Labs, which is equipped with an experienced team of product development talent, advanced vaporizer technology and analytical testing infrastructure, serves as the global center of R&D for the Company’s vaporizer devices.
One company we've highlighted in the past CleanSpark, Inc. (CLSK) has developed power solution for the cannabis industry that can reduce energy costs by up to 82%. This represents a huge potential revenue stream for the company. Due to this fact the company has stated that marketing to cannabis companies is one of their top initiatives for 2019.
One industry that is often overlooked but could play a huge role in the cannabis industry is energy. The U.S. cannabis industry is currently eating up more than 1% of all electricity each year. The need to reduce greenhouse emissions created by the weed industry, as well as lower electric load and expenditures, makes the energy sector a clear beneficiary of a budding cannabis industry.
DENVER , April 17, 2019 /CNW/ -- Ever since the Farm Bill was signed into law, farmers across the United States have rushed into hemp cultivation, driving demand for the supplies needed to grow the crop necessary to meet surging CBD use. Global hemp industry to reach $22 billion in 2022. Hemp is booming across the country, and nowhere more so than in Kentucky , where the applications to grow hemp are expected to increase fivefold, and acreage dedicated to growing the crop is set to more than triple this year.
HENDERSON, NV / ACCESSWIRE / April 10, 2019 / Several Canada-based marijuana growers could be impacted by a build-up of un-sellable "sub-par quality" cannabis, as well as a slower rollout of ...
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”), will announce its financial results for the first quarter ended March 31, 2019, and hold its First Quarter 2019 Earnings Conference Call on Thursday, May 9, 2019 at 8:30 a.m. EDT. A live audio webcast of the earnings call will be available on the Company’s website at https://ir.thecronosgroup.com/events-presentations. The call will be archived on the Company’s website for replay.
CORAL GABLES, FL / ACCESSWIRE / April 4, 2019 / When speaking about the marijuana stock market, one cannot help but bring into the conversation the importance of companies with ancillary functions in the cannabis sector. ParcelPal Technology Inc (PTNYF) (PKG), Innovative Industrial Properties Inc (IIPR), Charlotte's Web Holding Corp (CWBHF), and Cronos Group Inc (NASDAQ: CRON, TSX: CRON) are 4 pot stocks heating things up on Thursday. ParcelPal Technology Inc (PTNYF) (PKG) today announced that the Company will be hosting an investor update conference call on May 17th, 2019 for the purpose of reviewing the Company's recent progress as well as provide investors with plans for the future.
The illicit cannabis industry is estimated at $50 billion yearly, much of which will move out of the shadows and become a legal market in the coming years. One research firm estimates the legal trade could be worth $21 billion by 2021. Item 9 Labs (INLB) could be one of these as they finish a major expansion project on their Arizona cannabis cultivation and production facility, doubling capacity.
Cannabis retail has rapidly emerged as one of the most important components of the marijuana value chain. Not only do retail gatekeepers control one of the most intimate parts of the cannabis purchasing experience, but they do so at a premium — making cannabis retail a likely determinant of any marijuana company’s staying power. In this article, we explore some of the leading cannabis retail brands in Canada.
HENDERSON, NV / ACCESSWIRE / March 26, 2019 / According to Motley Fool, "Aurora Cannabis, Canopy Growth, and Tilray combined made less than $150 million in the last quarter, yet all three marijuana ...
Closed C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Completed first harvest in Peace Naturals expansion to Building 4 Launched Two Recreational.
HENDERSON, NV / ACCESSWIRE / March 19, 2019 / From a dirty little secret to one of the fastest growing industries in the world, cannabis has come a long way. As more states are legalizing medical marijuana ...
In regards to the cannabis industry's recent bull run, the positive trends can be attributed to two key factors: legislative efforts and a general shift in public opinion. Recently, lawmakers have advocated for legislation in support of cannabis legislation, and this has given cannabis companies more societal credibility. Transcanna Holdings Inc (TCAN.CN), Aphria Inc (NYSE:APHA), Harvest Health & Recreation Inc (HARV.CN), and Cronos Group Inc (CRON) are four cannabis companies worth looking into.
HENDERSON, NV / ACCESSWIRE / March 11, 2019 / From the beginning of the year (YTD) to March 9, 2019, the first tradable cannabis ETF, the Horizons Marijuana Life Sciences Index ETF, was up over 50%. Unfortunately, ...